APAC Non-Vascular Stents Market Research Report – Segmented By End User, Material, Type and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029)

Updated On: January, 2024
ID: 6578
Pages: 145

APAC Non-Vascular Stents Market Size (2023 to 2028)

The size of the Non-Vascular Stents market in the Asia Pacific was around USD 237.75 million in 2023. It is expected to grow at a CAGR of 6% to reach USD 318.17 million by 2028. It captures 23% of the global market.

The market for non-vascular stents in the APAC is expected to be driven by the rising frequency of chronic disorders primarily. Pulmonary stents widen restricted airways and aid the breathing process in conditions such as chronic obstructive pulmonary disease, central airway obstruction, and asthma. As a result, the Non-Vascular Stents Market in the APAC is expected to expand at a healthy rate between 2023 and 2028.

During the forecast period, the market is further expected to rise due to an increase in the geriatric population, the frequency of chronic and other diseases, and an increase in per capita healthcare spending. In addition, market growth is expected to be aided by the rise in the adoption of minimally invasive operations worldwide.

Lung cancer, pancreatic cancer, gallbladder cancer, colorectal cancer, stroke, asthma, Chronic Obstructive Pulmonary Disease, chronic pancreatitis, prostate cancer, and glaucoma are among the chronic diseases that the senior population is prone to develop, which is expected to fuel the growth rate for non-vascular stents in the APAC region over the forecast period. In addition, as the incidence of gastrointestinal cancer rises, the market for non-vascular stents is likely to expand.

However, the rise of the APAC non-vascular stents market is projected to be hampered by stringent government regulations in several developing countries, such as India and China, and safety concerns. The APAC Non-Vascular Stents Market is also estimated to be stifled by the high cost of non-vascular stents. As a result of numerous preventive measures and other restrictions imposed by regulatory bodies across the Asia-Pacific region due to COVID-19, severe disruptions in their respective production and supply-chain operations have occurred.

This research report on the Asia Pacific Non-Vascular Stents Market has been segmented and sub-segmented into the following categories:

By Type:

  • Pancreatic and Biliary Stents
    • Biliary Stents
    • Pancreatic Stents
  • Gastrointestinal Stents
  • Airway Stents
  • Urinary Tract Stents

By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Material:

  • Metallic Stents
  • Non-Metallic Stents

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, Asia Pacific is expected to register higher CAGR over the forecast period compared to other regions due to favorable government initiatives for using such medical devices, the rising geriatric population, and increasing healthcare expenditure.

Due to the expanding medical technology sector and the rising prevalence of stomach cancer in the countries, Asia Pacific is likely to have a significant market share over the forecast period. Because of government measures encouraging such medical gadgets, a growing senior population, and rising healthcare costs. Over the forecast period, technological advancements such as the development of radioactive and biodegradable stents, advanced stent designs and material composition, and newer stent placement techniques such as Endoscopic Ultrasound-guided stenting are expected to aid in the growth of the non-vascular stents market.


A few promising companies operating in the Asia Pacific Non-Vascular Stents Market profiled in this report are CONMED Corporation. Other players in the market include Taewoong Medical Co., Medtronic; C. R. Bard, Inc.; Boston Scientific Corporation; HOBBS MEDICAL, INC; Cook Medical; ELLA - CS, s.r.o.; Ltd.; Synchron Med Inc.; and Glaukos Corporation.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample